UiPath's Q1 2024 financial results were below analysts' expectations. The company reported a wider net loss than expected and slower revenue growth than anticipated. Therefore it is an opportune time to accumulate #PATH UiPath Inc with a $21 target.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.